At a press briefing in Geneva on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said the new hub will be in South Korea and wil...

In initial trade, London's benchmark FTSE 100 index reversed 0.9 percent to 7,047.14 points.

Moderna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...

On Aug. 26, Japan said it had halted the use of 1.63 million Moderna doses shipped to 863 vaccination centres nationwide as a precaution.

A Health Ministry official said Takeda first found out about the contaminated shots on Aug. 16 and reported the issue to the government on ...

With this, Johnson and Johnson became third foreign-made vaccine to get nod after Sputnik V, Moderna; permission is only for imports of the...

Moderna's announcement comes after pharmaceutical giant Pfizer Inc. said its COVID-19 vaccine remained effective months after the second do...

Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevati...

Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. T...

The French pharmaceutical company Sanofi will help manufacture the Moderna coronavirus vaccine beginning in September, joining other compan...

The bloc, with a population of nearly 450 million, has already booked a total of almost 2.3 billion doses from six vaccine makers. Most vac...

The distribution of Moderna's vaccine to more than 3,700 locations in the United States will vastly widen the rollout started last week by ...

Moderna on Monday said the independent National Institutes of Health-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of...

The Moderna vaccine candidate is an RNA-based vaccine designed to help the body produce antibodies that protect against Covid-19.

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...

Wipro founder-chairman Azim Premji owns a minority stake in US biotech company Moderna, which is developing a vaccine that could potentiall...

Moderna’s experimental shot induces the body’s own cells to make virus-like proteins that stimulate an immune response and prepare for an a...